Methadone Maintenance Programs
The history of methadone treatment offers a striking example of the benefits and limits of research findings on public attitudes and policies for methadone maintenance treatment. To understand methadone maintenance treatment, it is necessary to appreciate the profound stigma attached to both patients and treatment providers. This establishes the context for understanding how a modality with the most extensive research base in the addiction treatment field nonetheless can engender passionate dispute.
Methadone maintenance as a treatment modality was developed in the mid-1960s by Vincent Dole and Marie Nyswander in response to prevailing concerns about epidemic levels of heroin addiction and related health problems, mortality (especially among young people 15 to 35 years old) and high relapse rates. Methadone itself had been synthesized in Germany in World War II as a synthetic analgesic and was studied at the U.S. Public Health Service Hospital in Lexington, Kentucky, after the war. It was approved by the U.S. Food & Drug Administration in August 1947 for use in the treatment of pain. Its initial use in the treatment of addiction was to ease withdrawal in addicts being treated for heroin addiction; it was subsequently determined to be well suited to long-term maintenance treatment.
This page contains 201 words.
Methadone Maintenance Programs article
Read the rest of this article.
This article contains 3,833 words
(approx. 13 pages at 300 words per page).
Order our Methadone Article
